Cefixime Patent Expiration
Cefixime is Used for treating bacterial infections. It was first introduced by Lederle Laboratories Div American Cyanamid Co
Cefixime Patents
Given below is the list of patents protecting Cefixime, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Suprax | US9233112 | Pharmaceutical compositions of cefixime | Dec 14, 2028 | Lupin Ltd |
Cefixime's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Cefixime:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies | New York Medical College | NA |
RECRUITING
(Apr 1, 2026)
| PHASE1 |
| Cefixime Clinical Trial | University of Southern California | NA |
RECRUITING
(Apr 1, 2026)
| PHASE3 |
| Triple Antibiotic Paste vs Simvastatin for Lesion Sterilization and Tissue Repair in Primary Molars. | Dow University of Health Sciences | NA |
RECRUITING
(Mar 1, 2026)
| PHASE2 |